Total Payments
$7,116
2024 Payments
$280.92
Companies
33
Transactions
298
Medicare Patients
652
Medicare Billing
$68,970
Payment Breakdown by Category
Food & Beverage$7,024 (98.7%)
Education$92.07 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,024 | 289 | 98.7% |
| Education | $92.07 | 9 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,592 | 60 | $0 (2024) |
| Novo Nordisk Inc | $1,240 | 51 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $462.71 | 25 | $0 (2023) |
| ABBVIE INC. | $378.16 | 21 | $0 (2024) |
| Amgen Inc. | $363.97 | 16 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $313.23 | 16 | $0 (2021) |
| PFIZER INC. | $308.37 | 14 | $0 (2023) |
| Lilly USA, LLC | $282.45 | 18 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $201.96 | 13 | $0 (2020) |
| Medtronic, Inc. | $200.71 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $280.92 | 10 | Medtronic, Inc. ($89.85) |
| 2023 | $604.50 | 21 | Novo Nordisk Inc ($195.98) |
| 2022 | $781.26 | 37 | AstraZeneca Pharmaceuticals LP ($276.15) |
| 2021 | $1,276 | 49 | AstraZeneca Pharmaceuticals LP ($604.00) |
| 2020 | $684.81 | 35 | AstraZeneca Pharmaceuticals LP ($152.11) |
| 2019 | $475.36 | 27 | SANOFI-AVENTIS U.S. LLC ($67.51) |
| 2018 | $1,615 | 66 | PFIZER INC. ($225.97) |
| 2017 | $1,398 | 53 | Novo Nordisk Inc ($473.09) |
All Payment Transactions
298 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $32.62 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $31.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Cardio-renal | ||||||
| 06/13/2024 | Seqirus USA Inc | Flucelvax (Biological), Fluad | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Vaccines | ||||||
| 05/16/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $89.85 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 04/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: NEUROSCIENCE | ||||||
| 03/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Inflammation | ||||||
| 01/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Inflammation | ||||||
| 12/06/2023 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: Pharma Products | ||||||
| 12/04/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Cardio-renal | ||||||
| 11/06/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/07/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2023 | Supernus Pharmaceuticals, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 05/25/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Diabetes | ||||||
| 05/09/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/08/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: Diabetes | ||||||
| 04/18/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Diabetes | ||||||
| 04/18/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $1.22 | General |
| Category: Diabetes | ||||||
| 04/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/11/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Diabetes | ||||||
| 03/28/2023 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 175 | 330 | $72,090 | $20,234 |
| 2022 | 5 | 162 | 290 | $49,930 | $17,082 |
| 2021 | 11 | 259 | 424 | $70,710 | $26,752 |
| 2020 | 3 | 56 | 83 | $14,325 | $4,903 |
Total Patients
652
Total Services
1,127
Medicare Billing
$68,970
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 78 | $25,740 | $6,224 | 24.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 22 | 84 | $15,120 | $5,236 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 74 | $17,020 | $4,007 | 23.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 24 | $8,070 | $2,407 | 29.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 23 | 32 | $5,760 | $2,040 | 35.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 28 | 38 | $380.00 | $319.20 | 84.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 129 | $20,845 | $7,255 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 58 | $16,150 | $5,056 | 31.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 44 | $7,040 | $2,496 | 35.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 17 | 17 | $5,475 | $2,150 | 39.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 34 | 42 | $420.00 | $124.50 | 29.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 77 | $15,400 | $6,396 | 41.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 39 | 87 | $10,925 | $4,932 | 45.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 20 | 63 | $7,640 | $3,693 | 48.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 19 | 21 | $11,929 | $3,385 | 28.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 17 | 33 | $8,298 | $2,774 | 33.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 18 | 18 | $4,500 | $1,869 | 41.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 23 | 27 | $5,513 | $1,592 | 28.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 13 | $4,395 | $1,441 | 32.8% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 12 | 12 | $480.00 | $480.00 | 100.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 33 | 43 | $430.00 | $129.00 | 30.0% |
| 96127 | Brief emotional or behavioral assessment | Office | 2021 | 27 | 30 | $1,200 | $62.72 | 5.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 26 | 46 | $10,300 | $3,694 | 35.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 22 | $3,800 | $1,164 | 30.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 14 | 15 | $225.00 | $45.00 | 20.0% |
About Dr. Jeevan Gowda, MD
Dr. Jeevan Gowda, MD is a Internal Medicine healthcare provider based in Lake Jackson, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/11/2008. The National Provider Identifier (NPI) number assigned to this provider is 1881862027.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeevan Gowda, MD has received a total of $7,116 in payments from pharmaceutical and medical device companies, with $280.92 received in 2024. These payments were reported across 298 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($7,024).
As a Medicare-enrolled provider, Gowda has provided services to 652 Medicare beneficiaries, totaling 1,127 services with total Medicare billing of $68,970. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Lake Jackson, TX
- Active Since 02/11/2008
- Last Updated 12/18/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1881862027
Products in Payments
- FARXIGA (Drug) $1,333
- VRAYLAR (Drug) $343.70
- Ozempic (Drug) $332.49
- ENTRESTO (Drug) $313.23
- Victoza (Drug) $259.16
- BREZTRI (Drug) $226.42
- TRULICITY (Drug) $211.92
- INTERSTIM (Device) $200.71
- XARELTO (Drug) $180.56
- AUSTEDO (Drug) $145.36
- Senza Spinal Cord Stimulation System (Device) $144.09
- Prolia (Biological) $142.94
- SOLIQUA 100/33 (Biological) $142.25
- Trintellix (Drug) $141.30
- CONTRAVE (Drug) $135.31
- Wegovy (Drug) $134.80
- BELSOMRA (Drug) $125.75
- Tresiba (Drug) $122.40
- TOUJEO (Drug) $117.29
- Repatha (Biological) $109.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lake Jackson
Rajesh Dalal, Md, MD
Internal Medicine — Payments: $9,394
Internal Medicine $9,394
Dr. Frank Okosun, M.d, M.D
Internal Medicine — Payments: $4,989
Internal Medicine $4,989
Dr. Mustanser Badar, Md, Mph, Rpvi, MD, MPH, RPVI
Internal Medicine — Payments: $2,537
Internal Medicine $2,537
Alkesh Amin, Md, MD
Internal Medicine — Payments: $611.32
Internal Medicine $611.32